Nuvalent, Inc. (NUVL)
NASDAQ: NUVL · Real-Time Price · USD
90.34
-0.65 (-0.71%)
Nov 13, 2024, 4:00 PM EST - Market closed
Nuvalent Employees
Nuvalent had 92 employees as of December 31, 2023. The number of employees increased by 30 or 48.39% compared to the previous year.
Employees
92
Change (1Y)
30
Growth (1Y)
48.39%
Revenue / Employee
n/a
Profits / Employee
-$2,437,880
Market Cap
6.42B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 92 | 30 | 48.39% |
| Dec 31, 2022 | 62 | 22 | 55.00% |
| Dec 31, 2021 | 40 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| R1 RCM | 30,000 |
| Bausch + Lomb | 13,300 |
| Elanco Animal Health | 9,800 |
| RadNet | 8,441 |
| Legend Biotech | 1,826 |
| Ionis Pharmaceuticals | 927 |
| Blueprint Medicines | 655 |
| Cytokinetics | 423 |
NUVL News
- 1 day ago - Nuvalent Highlights Corporate and Pipeline Achievements, Reiterates Key Anticipated Milestones, and Reports Third Quarter 2024 Financial Results - PRNewsWire
- 7 weeks ago - Nuvalent: Promising Data Keeps Validating Pipeline And Platform - Seeking Alpha
- 2 months ago - Nuvalent Announces Closing of Upsized Public Offering of Common Stock - PRNewsWire
- 2 months ago - Nuvalent: NSCLC Program Now Lends Credibility Towards 2025 Pivotal Data Releases - Seeking Alpha
- 2 months ago - Nuvalent Announces Pricing of Upsized Public Offering of Common Stock - PRNewsWire
- 2 months ago - Nuvalent Stock Jumps On ESMO Data Presentation, Seeks To Raise $350M Via Equity - Benzinga
- 2 months ago - Cancer Biotech Nuvalent's Stock Jumps on Positive Data - Barrons
- 2 months ago - Nuvalent Announces Public Offering of Common Stock - PRNewsWire